Cellectar signals NDA submission for iopofosine I-131 in WM by early 2026 amid accelerated approval focus Cellectar signals NDA submission for iopofosine I-131 in WM by early 2026 amid accelerated approval focus Post ContentclrbRead More You might also be interested in reading What app instead of Binance?. August 14, 2025 In Mainstream ← Previous post Next post →